Takeda Pharmaceutical Company Limited Revenue From Performance Obligations Satisfied Or Partially Satisfied In Previous Periods
Takeda Pharmaceutical Company Limited (TKPHF) reported Revenue From Performance Obligations Satisfied Or Partially Satisfied In Previous Periods of JPY 97.56 billion for the 12-month period ending 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueFromPerformanceObligationsSatisfiedOrPartiallySatisfiedInPreviousPeriods · last filed 2025-06-25
| Period end | Revenue From Performance Obligations Satisfied Or Partially Satisfied In Previous Periods 12 month |
|---|---|
| 2025-03-31 | 97.56B JPY 20-F · filed 2025-06-25 |
| 2024-03-31 | 80.79B JPY 20-F · filed 2025-06-25 |
| 2023-03-31 | 79.25B JPY 20-F · filed 2025-06-25 |
| 2022-03-31 | 49.22B JPY 20-F · filed 2024-06-26 |
| 2021-03-31 | 57.90B JPY 20-F · filed 2023-06-28 |
| 2020-03-31 | 48.83B JPY 20-F · filed 2022-06-29 |
| 2019-03-31 | 53.93B JPY 20-F · filed 2020-06-24 |